Difference between revisions of "Research:MRNA vaccine"
Jump to navigation
Jump to search
(complying with new guidelines) |
(formatting) |
||
| Line 37: | Line 37: | ||
* | * | ||
===Keyness=== | ===Keyness=== | ||
>1000 | |||
Latest revision as of 20:50, 7 March 2022
Research
Variants and synonyms
Definition/description
In addition, the induction of an effective immune response requires stimulation of the innate immune system by the mRNA vaccine.
Source: https://doi.org/10.3389/fimmu.2018.01963
These results indicate that non-replicating mRNA vaccines potently induce an immunological repertoire associated with the generation of high magnitude long-lived antibodies.
Source: https://doi.org/10.3389/fimmu.2018.01963
Examples
Moderna reports that mRNA-1273 is an mRNA vaccine targeting a prefusion-stabilized form of the S protein associated with SARS-CoV-2, which was selected by Moderna in collaboration with investigators at the NIAID Vaccine Research Center.
Source: https://doi.org/10.1021/acscentsci.0c00272
Collocations
- manufacture mRNA vaccine
- engineer mRNA vaccine
- optimize mRNA vaccine
- formulate mRNA vaccine
- administer mRNA vaccine
- deliver mRNA vaccine
- employ mRNA vaccine
- compose mRNA vaccine
- test mRNA vaccine
- mRNA vaccine protect
- mRNA vaccine feature
- mRNA vaccine offer
- mRNA vaccine induce
- mRNA vaccine target
- effective mRNA vaccine
- potent mRNA vaccine
- conventional mRNA vaccine
Keyness
>1000